← Back to Search

Behavioural Intervention

The Donor App for Kidney Failure

N/A

Recruiting

Led By Andrew Cameron, MD PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years of age

On the kidney-only or liver-only transplant waiting list at a collaborating center

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial uses a web app to help transplant patients on a waitlist communicate their need for a living donor, and provides potential donors the opportunity to engage with the evaluation process.

Who is the study for?

This trial is for adults over 18 who are on the waiting list for a kidney or liver transplant at a participating center. It's not open to those under 18, not on the transplant waitlist, or waiting for multiple organ transplants.Check my eligibility

What is being tested?

The study is testing 'The Donor App', which is designed to help patients in need of an organ transplant use social media to find living donors and allows potential donors to start the evaluation process.See study design

What are the potential side effects?

Since this trial involves using a web-based application rather than medical treatment, there are no direct physical side effects associated with traditional clinical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am on the waiting list for a kidney or liver transplant at a participating center.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Live donor transplantation

Potential donors identified

Secondary outcome measures

App utilization as assessed by number of participants with story completion and posting in the donor app

The Donor App Implementation

Trial Design

1Treatment groups

Experimental Treatment

Group I: The Donor AppExperimental Treatment1 Intervention

Select physicians and research staff from about 15 transplant hospitals will be given access to distribute the application to patients who the above people feel could benefit from the application. After obtaining informed consent, an approved member of the study team will enter the participant's name, contact info, and organ needed into the Donor App's secure management portal to send an email or text message with a unique and protected invitation link to the participant. Using this link the participant will be allowed to use the Donor App indefinitely.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Rush University Medical CenterOTHER

422 Previous Clinical Trials

162,531 Total Patients Enrolled

Scripps HealthOTHER

54 Previous Clinical Trials

10,792 Total Patients Enrolled

Yale UniversityOTHER

1,847 Previous Clinical Trials

2,736,668 Total Patients Enrolled

Media Library

The Donor App (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03803423 — N/A

Liver Disease Research Study Groups: The Donor App

Liver Disease Clinical Trial 2023: The Donor App Highlights & Side Effects. Trial Name: NCT03803423 — N/A

The Donor App (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03803423 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what venues are the trials of this clinical research being conducted?

"This experiment is being conducted at Scripps Green Hospital in San Diego, CA, The Johns Hopkins Hospital in Baltimore, MD, and Rush University Medical Center in Chicago il as well as 6 other medical centres."

Answered by AI

Is enrollment available for this clinical trial?

"According to clinicaltrials.gov, this ongoing medical trial is currently in need of participants since it was last updated on November 15th 2022 and initially posted on November 27th 2017."

Answered by AI

How many individuals are actively engaged in this clinical experiment?

"This clinical trial necessitates 1000 eligible patients. Possible venues for participation include The Johns Hopkins Hospital in Baltimore, Maryland and Scripps Green Hospital located in San Diego, California."

Answered by AI

Recent research and studies

American Journal of TransplantationJournal

A Smartphone App for Increasing Live Organ Donation

Kumar, K., E. A. King, A. D. Muzaale, J. M. Konel, K. A. Bramstedt, A. B. Massie, D. L. Segev, and A. M. Cameron. 2016. “A Smartphone App for Increasing Live Organ Donation”. American Journal of Transplantation. Wiley. doi:10.1111/ajt.13961.

American Journal of TransplantationJournal

Beyond the Billboard: The Facebook-based Application, Donor, and Its Guided Approach to Facilitating Living Organ Donation

Bramstedt, K. A., and A. M. Cameron. 2016. “Beyond the Billboard: The Facebook-based Application, Donor, and Its Guided Approach to Facilitating Living Organ Donation”. American Journal of Transplantation. Wiley. doi:10.1111/ajt.14004.

clinicaltrials.govStudy

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

2017. "Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03803423.

All > Liver Disease > Paid Studies Maine